1,862 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Alexandria Investments

Alexandria has invested in 215 companies and its latest investment was Latigo on Mar 16, 2025

Unlock 212 more investments →

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Latigo is a California-based clinical-stage biotechnology company that researches and develops non-opioid medicines for the treatment of chronic pain.
$150M
Mar 16, 2025
-
$11M
Mar 05, 2025
-
Eikon is a California-based biotechnology company that offers solutions such as drug discovery and development for the pharmaceutical sector.
$350.7M
Feb 25, 2025
-
Umoja is a Washington-based biotechnology company that develops and commercializes CAR T-cell therapies for the treatment of cancer.
$100M
Jan 13, 2025
-
Nuvig is a California-based biopharmaceutical firm that researches and develops novel therapies for the treatment for chronic autoimmune diseases.
$161M
Dec 04, 2024
-

Frequently Asked Questions about Alexandria

  1. What is Alexandria investing in?

    Alexandria has invested in 215 companies including Latigo, Avalo and Eikon

  2. What company did Alexandria invest in?

    Alexandria invested in a total 215 companies including Latigo, Avalo and Eikon

  1. What are the top 5 investments by Alexandria?

    The top companies in which Alexandria invested are Latigo, Avalo, Eikon, Umoja and Nuvig